Wrap up interview: PCI in diabetic patients: turning challenges into today's solution
PCI in diabetics - Cre8 polymer-free DES technology by Alvimedica
With the dramatic increase in diabetes worldwide, treating diabetic patients with PCI is a growing challenge. This is a scenario where existing DES have failed and where, among other things, we need to “deliver the drug directly into the diabetic cell”. Can a newer-generation stent improve clinical outcomes for diabetics? Join S. Verheye, A. Colombo and G. Sardella as they speak about PCI in diabetics and Cre8, a new stent whose innovative architecture and unique drug-eluting properties might be a key in treating these patients. Does the drug formulation itself target the diabetic cell? Do clinical results, studies and live cases presented during the meeting offer promise?
Join us here for this interesting discussion…